Addendum: The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials

被引：0
|
作者：
Soheil Hassanipour
Morteza Arab-Zozani
Bahman Amani
Forough Heidarzad
Mohammad Fathalipour
Rudolph Martinez-de-Hoyo
机构：
[1] Guilan University of Medical Sciences,Gastrointestinal and Liver Diseases Research Center
[2] Birjand University of Medical Sciences,Social Determinants of Health Research Center
[3] Tehran University of Medical Sciences,Department of Health Management and Economics, School of Public Health
[4] Hormozgan University of Medical Sciences,Department of Pharmacology and Toxicology, Faculty of Pharmacy
[5] MSN Labs Americas,undefined
来源：
Scientific Reports | / 12卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
    Hassanipour, Soheil
    Arab-Zozani, Morteza
    Amani, Bahman
    Heidarzad, Forough
    Fathalipour, Mohammad
    Martinez-de-Hoyo, Rudolph
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [2] The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials
    Soheil Hassanipour
    Morteza Arab-Zozani
    Bahman Amani
    Forough Heidarzad
    Mohammad Fathalipour
    Rudolph Martinez-de-Hoyo
    Scientific Reports, 11
  • [3] Efficacy and Safety of Favipiravir for the Treatment of COVID-19 Outpatients: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Cheema, Huzaifa Ahmad
    Ali, Abraish
    Ali, Mirha
    Shahid, Abia
    Ghafoor, Muhammad Saqib
    Ur Rehman, Mohammad Ebad
    Sah, Ranjit
    Sahra, Syeda
    Ahmad, Sharjeel
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (03) : e328 - e331
  • [4] The efficacy and safety of favipiravir in the treatment of nonsevere COVID-19: a systematic review and meta-analysis of randomized controlled trials
    Bahar, M. A.
    Kusuma, I. Y.
    Matuz, M.
    Ferenci, T.
    Benko, R.
    Csupor, D.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2022, 44 (06) : 1491 - 1491
  • [5] The efficacy and safety of Favipiravir in treatment of COVID-19: a systematic review and meta-analysis of clinical trials (vol 11, 11022, 2021)
    Hassanipour, Soheil
    Arab-Zozani, Morteza
    Amani, Bahman
    Heidarzad, Forough
    Fathalipour, Mohammad
    Martinez-de-Hoyo, Rudolph
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [6] Efficacy and Safety of COVID-19 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Pormohammad, Ali
    Zarei, Mohammad
    Ghorbani, Saied
    Mohammadi, Mehdi
    Razizadeh, Mohammad Hossein
    Turner, Diana L.
    Turner, Raymond J.
    VACCINES, 2021, 9 (05)
  • [7] Efficacy and Safety of Fluvoxamine as Outpatient Treatment for Patients With Covid-19: A Systematic Review and Meta-analysis of Clinical Trials
    Vatvani, Akhil Deepak
    Kurniawan, Andree
    Hariyanto, Timotius Ivan
    ANNALS OF PHARMACOTHERAPY, 2023, 57 (12) : 1389 - 1397
  • [8] Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
    Toshie Manabe
    Dan Kambayashi
    Hiroyasu Akatsu
    Koichiro Kudo
    BMC Infectious Diseases, 21
  • [9] Favipiravir for the treatment of patients with COVID-19: a systematic review and meta-analysis
    Manabe, Toshie
    Kambayashi, Dan
    Akatsu, Hiroyasu
    Kudo, Koichiro
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [10] Efficacy and safety of azithromycin in Covid-19 patients: A systematic review and meta-analysis of randomized clinical trials
    Kamel, Ahmed M.
    Monem, Mona S. A.
    Sharaf, Nour A.
    Magdy, Nada
    Farid, Samar F.
    REVIEWS IN MEDICAL VIROLOGY, 2022, 32 (01)
12345